Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher N Johnson

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Journal of Medicinal Chemistry|May 8, 2025
Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"James E H Day, Valerio Berdini, Joan Castro, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Multiplexed Assays of Variant Effect and Automated Patch-clamping Improve <i>KCNH2</i>-LQTS Variant Classification and Cardiac Event Risk StratificationMatthew J O'Neill, Chai-Ann Ng, Takanori Aizawa, et al.
Journal of Medicinal Chemistry|March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.
Journal of Medicinal Chemistry|March 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein InteractionGianni Chessari, Ian R Hardcastle, Jong Sook Ahn, et al.
The Journal of Clinical Investigation|November 1, 2019
KBTBD13 is an actin-binding protein that modulates muscle kineticsJosine M de Winter, Joery P Molenaar, Michaela Yuen, et al.
The Journal of Clinical Investigation|February 1, 2024
KBTBD13 is an actin-binding protein that modulates muscle kineticsJosine M de Winter, Joery P Molenaar, Michaela Yuen, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Journal of Medicinal Chemistry|May 8, 2025
Correction to "Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)"James E H Day, Valerio Berdini, Joan Castro, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Multiplexed Assays of Variant Effect and Automated Patch-clamping Improve <i>KCNH2</i>-LQTS Variant Classification and Cardiac Event Risk StratificationMatthew J O'Neill, Chai-Ann Ng, Takanori Aizawa, et al.
Journal of Medicinal Chemistry|March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.
Journal of Medicinal Chemistry|March 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein InteractionGianni Chessari, Ian R Hardcastle, Jong Sook Ahn, et al.
The Journal of Clinical Investigation|November 1, 2019
KBTBD13 is an actin-binding protein that modulates muscle kineticsJosine M de Winter, Joery P Molenaar, Michaela Yuen, et al.
The Journal of Clinical Investigation|February 1, 2024
KBTBD13 is an actin-binding protein that modulates muscle kineticsJosine M de Winter, Joery P Molenaar, Michaela Yuen, et al.
Pageof 15